← All trials
NCT04565756
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 5, 2020
- Primary completion
- Nov 15, 2021
- Completion date
- May 20, 2022
- First posted
- Sep 25, 2020
- Last posted
- Dec 30, 2020
- Enrollment
- 48
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Exonate LimitedLead sponsor
- NovotechCollaborator
- Adelaide Eye and Retina CentreOverall official - principal investigator
- Centre for Eye Research Australia (CERA)Overall official - principal investigator
- Lions Eye InstituteOverall official - principal investigator
- Newcastle Eye Hospital FoundationOverall official - principal investigator
- Strathfield Retina ClinicOverall official - principal investigator
- Sydney Eye Hospital/Save Sight InstitutionOverall official - principal investigator
- Sydney Retina Clinic & Day SurgeryOverall official - principal investigator
- ZAVe Clinical Research Management - Retinology InstituteOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.